Cargando…

Complexity Analysis of EEG, MEG, and fMRI in Mild Cognitive Impairment and Alzheimer’s Disease: A Review

Alzheimer’s disease (AD) is a degenerative brain disease with a high and irreversible incidence. In recent years, because brain signals have complex nonlinear dynamics, there has been growing interest in studying complex changes in the time series of brain signals in patients with AD. We reviewed st...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jie, Wang, Bin, Niu, Yan, Tan, Yuan, Fan, Chanjuan, Zhang, Nan, Xue, Jiayue, Wei, Jing, Xiang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516672/
https://www.ncbi.nlm.nih.gov/pubmed/33286013
http://dx.doi.org/10.3390/e22020239
_version_ 1783587054857224192
author Sun, Jie
Wang, Bin
Niu, Yan
Tan, Yuan
Fan, Chanjuan
Zhang, Nan
Xue, Jiayue
Wei, Jing
Xiang, Jie
author_facet Sun, Jie
Wang, Bin
Niu, Yan
Tan, Yuan
Fan, Chanjuan
Zhang, Nan
Xue, Jiayue
Wei, Jing
Xiang, Jie
author_sort Sun, Jie
collection PubMed
description Alzheimer’s disease (AD) is a degenerative brain disease with a high and irreversible incidence. In recent years, because brain signals have complex nonlinear dynamics, there has been growing interest in studying complex changes in the time series of brain signals in patients with AD. We reviewed studies of complexity analyses of single-channel time series from electroencephalogram (EEG), magnetoencephalogram (MEG), and functional magnetic resonance imaging (fMRI) in AD and determined future research directions. A systematic literature search for 2000–2019 was performed in the Web of Science and PubMed databases, resulting in 126 identified studies. Compared to healthy individuals, the signals from AD patients have less complexity and more predictable oscillations, which are found mainly in the left parietal, occipital, right frontal, and temporal regions. This complexity is considered a potential biomarker for accurately responding to the functional lesion in AD. The current review helps to reveal the patterns of dysfunction in the brains of patients with AD and to investigate whether signal complexity can be used as a biomarker to accurately respond to the functional lesion in AD. We proposed further studies in the signal complexities of AD patients, including investigating the reliability of complexity algorithms and the spatial patterns of signal complexity. In conclusion, the current review helps to better understand the complexity of abnormalities in the AD brain and provide useful information for AD diagnosis.
format Online
Article
Text
id pubmed-7516672
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75166722020-11-09 Complexity Analysis of EEG, MEG, and fMRI in Mild Cognitive Impairment and Alzheimer’s Disease: A Review Sun, Jie Wang, Bin Niu, Yan Tan, Yuan Fan, Chanjuan Zhang, Nan Xue, Jiayue Wei, Jing Xiang, Jie Entropy (Basel) Review Alzheimer’s disease (AD) is a degenerative brain disease with a high and irreversible incidence. In recent years, because brain signals have complex nonlinear dynamics, there has been growing interest in studying complex changes in the time series of brain signals in patients with AD. We reviewed studies of complexity analyses of single-channel time series from electroencephalogram (EEG), magnetoencephalogram (MEG), and functional magnetic resonance imaging (fMRI) in AD and determined future research directions. A systematic literature search for 2000–2019 was performed in the Web of Science and PubMed databases, resulting in 126 identified studies. Compared to healthy individuals, the signals from AD patients have less complexity and more predictable oscillations, which are found mainly in the left parietal, occipital, right frontal, and temporal regions. This complexity is considered a potential biomarker for accurately responding to the functional lesion in AD. The current review helps to reveal the patterns of dysfunction in the brains of patients with AD and to investigate whether signal complexity can be used as a biomarker to accurately respond to the functional lesion in AD. We proposed further studies in the signal complexities of AD patients, including investigating the reliability of complexity algorithms and the spatial patterns of signal complexity. In conclusion, the current review helps to better understand the complexity of abnormalities in the AD brain and provide useful information for AD diagnosis. MDPI 2020-02-20 /pmc/articles/PMC7516672/ /pubmed/33286013 http://dx.doi.org/10.3390/e22020239 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Sun, Jie
Wang, Bin
Niu, Yan
Tan, Yuan
Fan, Chanjuan
Zhang, Nan
Xue, Jiayue
Wei, Jing
Xiang, Jie
Complexity Analysis of EEG, MEG, and fMRI in Mild Cognitive Impairment and Alzheimer’s Disease: A Review
title Complexity Analysis of EEG, MEG, and fMRI in Mild Cognitive Impairment and Alzheimer’s Disease: A Review
title_full Complexity Analysis of EEG, MEG, and fMRI in Mild Cognitive Impairment and Alzheimer’s Disease: A Review
title_fullStr Complexity Analysis of EEG, MEG, and fMRI in Mild Cognitive Impairment and Alzheimer’s Disease: A Review
title_full_unstemmed Complexity Analysis of EEG, MEG, and fMRI in Mild Cognitive Impairment and Alzheimer’s Disease: A Review
title_short Complexity Analysis of EEG, MEG, and fMRI in Mild Cognitive Impairment and Alzheimer’s Disease: A Review
title_sort complexity analysis of eeg, meg, and fmri in mild cognitive impairment and alzheimer’s disease: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516672/
https://www.ncbi.nlm.nih.gov/pubmed/33286013
http://dx.doi.org/10.3390/e22020239
work_keys_str_mv AT sunjie complexityanalysisofeegmegandfmriinmildcognitiveimpairmentandalzheimersdiseaseareview
AT wangbin complexityanalysisofeegmegandfmriinmildcognitiveimpairmentandalzheimersdiseaseareview
AT niuyan complexityanalysisofeegmegandfmriinmildcognitiveimpairmentandalzheimersdiseaseareview
AT tanyuan complexityanalysisofeegmegandfmriinmildcognitiveimpairmentandalzheimersdiseaseareview
AT fanchanjuan complexityanalysisofeegmegandfmriinmildcognitiveimpairmentandalzheimersdiseaseareview
AT zhangnan complexityanalysisofeegmegandfmriinmildcognitiveimpairmentandalzheimersdiseaseareview
AT xuejiayue complexityanalysisofeegmegandfmriinmildcognitiveimpairmentandalzheimersdiseaseareview
AT weijing complexityanalysisofeegmegandfmriinmildcognitiveimpairmentandalzheimersdiseaseareview
AT xiangjie complexityanalysisofeegmegandfmriinmildcognitiveimpairmentandalzheimersdiseaseareview